Options MD operates a virtual-care platform focused on treatment-resistant depression, where patients complete a screening form and can have intake sessions with psychiatrists. The company offers a range of treatments including talk therapy, new medications, transcranial magnetic stimulation (TMS) and ketamine. Options MD says it is nurturing one of the country's largest communities for treatment-resistant depression and emphasizes comprehensive, personalized care. The startup plans to use new funding to expand clinical operations and research and to improve its proprietary clinical protocols. Financially, Options MD has raised pre-seed capital totaling nearly $4 million following its latest round and additional support from a Google for Startups Latino Founders Fund award.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Nov 2022